Ambrisentan

Results: 18



#Item
1Microsoft Word - GOCER03FEB.doc

Microsoft Word - GOCER03FEB.doc

Add to Reading List

Source URL: www.gilead.com

Language: English - Date: 2014-06-04 16:18:55
20000000000000000002041068

0000000000000000002041068

Add to Reading List

Source URL: www.gilead.com

Language: English - Date: 2014-06-04 16:18:58
3Microsoft Word - GOCER03FEB.doc

Microsoft Word - GOCER03FEB.doc

Add to Reading List

Source URL: www.gilead.com

Language: English - Date: 2014-06-04 16:18:57
4Microsoft Word - Begeleiding ZPP Ambrisentan.doc

Microsoft Word - Begeleiding ZPP Ambrisentan.doc

Add to Reading List

Source URL: www.healthbase.nl

Language: Dutch - Date: 2013-02-22 07:04:44
    5ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1  1.

    ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1.

    Add to Reading List

    Source URL: www.ema.europa.eu

    Language: English
    6PATIENT INFORMATION ON  AMBRISENTAN (Brand name: Volibris)  This information sheet has been produced by

    PATIENT INFORMATION ON AMBRISENTAN (Brand name: Volibris) This information sheet has been produced by

    Add to Reading List

    Source URL: www.rheumatology.org.au

    Language: English - Date: 2014-03-20 02:34:15
    7Ambrisentan (Letairis®) Issued by PHA’s Scientific Leadership Council Information is based on the United States Food and Drug Administration drug labeling Last Updated November[removed]WHAT IS AMBRISENTAN?

    Ambrisentan (Letairis®) Issued by PHA’s Scientific Leadership Council Information is based on the United States Food and Drug Administration drug labeling Last Updated November[removed]WHAT IS AMBRISENTAN?

    Add to Reading List

    Source URL: www.phassociation.org

    Language: English - Date: 2013-12-03 14:16:08
    8

    PDF Document

    Add to Reading List

    Source URL: www.england.nhs.uk

    Language: English - Date: 2013-08-13 12:09:38
    9Case3:11-cv[removed]EMC Document117 Filed01[removed]Page1 of[removed]

    Case3:11-cv[removed]EMC Document117 Filed01[removed]Page1 of[removed]

    Add to Reading List

    Source URL: www.fdalawblog.net

    Language: English - Date: 2015-01-14 06:34:29
    10Annals of Internal Medicine  Summaries for Patients Treatment of Idiopathic Pulmonary Fibrosis With Ambrisentan  The full report is titled

    Annals of Internal Medicine Summaries for Patients Treatment of Idiopathic Pulmonary Fibrosis With Ambrisentan The full report is titled

    Add to Reading List

    Source URL: annals.org

    Language: English